Related Experiment Video
Updated: May 13, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Getting 'Smad' about obesity and diabetes
C K Tan1, H C Chong, E H P Tan
1School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Nutrition & Diabetes
|March 2, 2013
Summary
Transforming growth factor-beta (TGF-β)/Smad3 signaling impacts obesity and type 2 diabetes by affecting fat cells, metabolism, and insulin. Inhibiting this pathway may offer new treatments for metabolic syndrome.
Area of Science:
- Molecular biology
- Endocrinology
- Metabolic research
Background:
- Transforming growth factor-beta (TGF-β) signaling is implicated in obesity and type 2 diabetes pathogenesis.
- Elevated TGF-β levels are observed in human adipose tissue in morbid obesity and diabetic neuropathy.
Purpose of the Study:
- To review the multifaceted roles of TGF-β/Smad3 signaling in metabolism and energy homeostasis.
- To explore the contribution of TGF-β/Smad3 signaling to obesity and associated diabetes.
- To discuss therapeutic strategies targeting TGF-β/Smad3 inhibition for metabolic disorders.
Main Methods:
- Review of existing literature on TGF-β/Smad3 signaling in metabolic regulation.
- Analysis of in vivo studies using Smad3 knockout (Smad3(-/-)) mice.
- Examination of Smad3's regulatory effects on peroxisome proliferator-activated receptor (PPAR) promoters.
Main Results:
- TGF-β/Smad3 signaling influences adipocyte differentiation, fat browning, glucose and lipid metabolism, and pancreatic function.
- Smad3 exhibits a dual regulatory role on PPARβ/δ and PPARγ2 promoters, suggesting a unifying mechanism in metabolic dysfunction.
- Inhibition of TGF-β/Smad3 signaling shows promise in ameliorating metabolic syndrome features.
Conclusions:
- TGF-β/Smad3 signaling is a key player in the development and progression of obesity and type 2 diabetes.
- Understanding the mechanisms of TGF-β/Smad3 signaling provides novel therapeutic targets for metabolic diseases.
- Targeted inhibition of TGF-β/Smad3 signaling represents a potential therapeutic avenue for metabolic syndrome.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...